Skip to main content
AdvisorShares Psychedelics ETF—— (—)Compass Pathways—— (—)Definium Therapeutics—— (—)GH Research—— (—)Helus Pharma—— (—)MIRA Pharmaceuticals—— (—)Neuphoria Therapeutics—— (—)Eli Lilly—— (—)Johnson & Johnson—— (—)AbbVie—— (—)Otsuka Pharmaceutical—— (—)Numinus Wellness—— (—)Optimi Health—— (—)PharmAla Biotech—— (—)Enveric Biosciences—— (—)Incannex Healthcare—— (—)Aurora Cannabis—— (—)Cronos Group—— (—)SNDL—— (—)Bright Minds Biosciences—— (—)PharmaTher Holdings—— (—)IM Cannabis—— (—)MariMed—— (—)Vireo Growth—— (—)
Loading prices

Professional Development

Harm Reduction International Conference 2027 (HR27)

A round conference table with blank research papers and chairs stands before a stylized Belfast cityscape.

Harm Reduction International Conference 2027 (HR27) takes place May 9–12, 2027, in Belfast, Northern Ireland, GB, convened by Harm Reduction International in a different city every two years. Four days of presentations, workshops, films, networking events and more provide a dynamic forum for sharing the latest research and discussions on best practice in drug use, harm reduction and human rights, attracting over 1,000 diverse delegates and speakers, including front-line health workers, academics, researchers, policy makers, politicians, UN representatives and an additional group left incomplete in the source as “people who”. Listed on the MAPS events calendar under Professional Development, the listing notes four sessions, with the first listed for May 10, 2027, at 2:00 AM.

Hosted with: Psychedelic Writers Guild